DMK Pharmaceuticals Accounts Payable

DMK Pharmaceuticals (DMKPQ) currently reports a accounts payable of $10B as of September 2023. That compares with $5.3M in the prior-year period — up 188158.7% year over year. Use the charts on this page to explore DMK Pharmaceuticals's accounts payable history and peer comparisons.

DMK Pharmaceuticals's accounts payable increased from $5.3M to $10B — a 188158.7% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DMK Pharmaceuticals reported $10B in accounts payable as of September 2023. That compares with $5.3M in the prior-year period — up 188158.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $10B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DMK Pharmaceuticals, and consider following DMKPQ for alerts when major investors trade the stock.

DMK Pharmaceuticals is classified in the Healthcare sector. On accounts payable, it currently shows $10B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DMKPQ with unrelated industries.